Umar Zahid
Impact in
-
- CAR-T cell therapy research
-
- Multiple Myeloma Research and Treatments
Papers in
- Oncology 11
- CAR-T cell therapy research 6
-
- Streptococcal Infections and Treatments 2
- Health and Medical Research Impacts 2
- Co-authors
- Faiz Anwer (14 shared papers)Irbaz Bin Riaz (12 shared papers)Ali McBride (9 shared papers)Muhammad Husnain (6 shared papers)Ahmad Iftikhar (8 shared papers)Daniel O. Persky (1 shared paper)Samuel Spitalewitz (2 shared papers)Onyee Chan (1 shared paper)
- Journals
- Blood (3 papers)Biology of Blood and Marrow Transplantation (2 papers)American Journal of Therapeutics (2 papers)Journal of Clinical Oncology (2 papers)Critical Reviews in Oncology/Hematology (1 paper)
- Partner nations
- United StatesPakistanIndia
In The Last Decade
Umar Zahid
34 papers receiving 460 citations
Peers
Comparison fields: 5 of 76
- Oncology 153
- Hematology 50
- Nephrology 30
- Infectious Diseases 58
- Gender Studies 27
Countries citing papers authored by Umar Zahid
This map shows the geographic impact of Umar Zahid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Zahid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Zahid more than expected).
Fields of papers citing papers by Umar Zahid
This network shows the impact of papers produced by Umar Zahid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Zahid. The network helps show where Umar Zahid may publish in the future.
Co-authors
The 25 scholars most cited alongside Umar Zahid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 75 | |
| 2 | 2020 | 70 | |
| 3 | 2017 | 67 | |
| 4 | 2020 | 40 | |
| 5 | 2019 | 37 | |
| 6 | 2018 | 33 | |
| 7 | 2017 | 21 | |
| 8 | 2018 | 13 | |
| 9 | 2019 | 11 | |
| 10 | 2017 | 11 | |
| 11 | 2018 | 10 | |
| 12 | 2017 | 9 | |
| 13 | 2018 | 8 | |
| 14 | 2019 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2014 | 5 | |
| 17 | 2014 | 5 | |
| 18 | 2016 | 4 | |
| 19 | 2018 | 4 | |
| 20 | 2023 | 4 |
About Umar Zahid
Umar Zahid is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Hematology, Infectious Diseases and Cardiology and Cardiovascular Medicine, having authored 35 papers that have together received 467 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Multiple Myeloma Research and Treatments (4 papers), Cardiac tumors and thrombi (3 papers), Sarcoma Diagnosis and Treatment (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Streptococcal Infections and Treatments (2 papers), Health and Medical Research Impacts (2 papers) and Advances in Oncology and Radiotherapy (2 papers). The work is most often cited by research in Oncology (153 citations), Hematology (50 citations), Nephrology (30 citations), Infectious Diseases (58 citations) and Gender Studies (27 citations). Umar Zahid has collaborated with scholars based in United States, Pakistan and India. Frequent co-authors include Faiz Anwer, Irbaz Bin Riaz, Ali McBride, Muhammad Husnain, Ahmad Iftikhar, Daniel O. Persky, Samuel Spitalewitz, Onyee Chan, Preethi Ramachandran and Muhammad Azhar. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, American Journal of Therapeutics, Journal of Clinical Oncology and Critical Reviews in Oncology/Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.